Repurposed Drug Relieves Psoriasis in Early Mouse Studies

Summary

Psoriasis is a chronic condition known for causing itchy, inflamed skin plaques, but it is also closely linked to the body's internal metabolism. In a recent study, researchers identified a specific gene called AKR1B10 that is unusually active in psoriasis. This gene is strongly tied to the presence of activated immune cells that drive the disease. To see if they could interrupt this process, scientists turned to an existing drug called Epalrestat, which is known to block the activity of this specific gene.

To test their theory, the research team treated mice that had a psoriasis-like skin condition with Epalrestat. The results were highly encouraging. The drug successfully healed skin lesions and significantly lowered standard scores used to measure psoriasis severity. When looking at safety, Epalrestat actually outperformed methotrexate, a powerful immunosuppressant drug commonly prescribed to patients today.

The researchers also uncovered exactly how the treatment works. By inhibiting the AKR1B10 gene, Epalrestat helps restore the natural balance of retinol, also known as vitamin A, in the body. Fixing this metabolic process creates a domino effect that indirectly shuts down IL-17, a major inflammatory signaling pathway responsible for psoriasis symptoms.

Why it matters.

Finding new uses for existing medications is a vital strategy in modern medicine because it can speed up the development of safer, more accessible treatments. Because psoriasis is often accompanied by metabolic syndrome, a drug that addresses both the metabolic and immune aspects of the disease could be highly valuable for patient care. The fact that Epalrestat showed a better safety profile than standard therapies like methotrexate suggests it could one day offer a gentler alternative for long-term management.

However, it is important to keep expectations grounded. The current efficacy and safety findings are based entirely on early-stage preclinical studies in mice. While these laboratory results provide a strong foundation, scientists will need to conduct extensive human clinical trials to confirm whether Epalrestat is truly a safe and effective option for people living with psoriasis.

From the source

The story in numbers.

AUC for AKR1B10 correlation with activated immune cells: 0.970
Administration routes tested (intragastric and topical): 2

Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

A $122M boost for a fast, inside-the-body approach to cell therapy

Create Medicines recently secured $122 million to advance a new class of treatments for cancer and autoimmune diseases. They specialize in CAR-T cell therapy, a treatment that engineers the immune system to fight disease. But instead of the traditional method of removing cells from a patient to alter them in a lab, Create Medicines is developing therapies that work entirely inside the body, a process known as "in vivo" treatment. To achieve this, the therapy uses tiny fat bubbles called lipid nanoparticles to deliver messenger RNA, or mRNA, into the patient. Think of mRNA as a set of biological instructions. Once delivered, these instructions directly teach the patient's existing immune cells, including T cells, natural killer cells, and myeloid cells, to reprogram themselves into disease fighters. The startup has already dosed more than 50 patients, giving it the largest clinical dataset in the in vivo field. They recently began an early-stage clinical trial for an experimental therapy designed to attack solid tumors that carry a specific protein called HER2. Alongside this cancer research, the company is testing other treatments that target proteins called CD19 and BCMA to help patients with autoimmune conditions.

BioPharma Dive1 min read

Supreme Court Protects Access to Common Abortion Pill

The United States Supreme Court has decided to preserve access to mifepristone, a medication used in the most common method of abortion. By rejecting recent restrictions proposed by lower courts, the Supreme Court has ensured that patients can still obtain this widely used drug while an ongoing lawsuit continues to make its way through the legal system. Under this current legal order, patients do not need an in-person visit with a doctor to get the medication. Instead, they are permitted to continue receiving mifepristone directly from pharmacies or through the mail. This ruling maintains the existing distribution methods, meaning that access is expected to remain uninterrupted at least into the following year as further legal proceedings unfold.

STAT News1 min read

Living Implants: Engineered Bacteria Trapped in Gel Fight Infections

What if a medical implant could sense an infection and fight it off automatically? Researchers have created exactly that with a new technology called an "implantable living material." To build it, scientists used a specialized, water-based gel known as a polyvinyl alcohol hydrogel. This material acts as a tiny, flexible fortress. It is uniquely stiff and tough, designed to hold genetically engineered bacteria safely inside for up to six months without them escaping into the surrounding tissue. Inside this protective gel, the researchers trapped a modified version of E. coli bacteria to act as molecular guards. These engineered microbes are programmed to detect chemical signals given off by Pseudomonas aeruginosa, a dangerous pathogen that frequently causes infections around artificial joints. When the trapped bacteria sense the invader, they trigger a targeted self-destruct mechanism. This intentional cellular explosion releases a powerful antibacterial protein that easily passes through the microscopic pores of the gel to kill the infection outside. The research team tested this system in mice with artificial joint infections. Over a three-day treatment period, the living implant significantly reduced the amount of infectious bacteria compared to non-therapeutic controls. By keeping the helpful microbes physically contained while allowing their medicine to flow out, the researchers have found a clever way to turn living cells into localized drug factories.

GEN2 min read

Follow your curiosity.

Repurposed Drug Relieves Psoriasis in Early Mouse Studies

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

A $122M boost for a fast, inside-the-body approach to cell therapy

Supreme Court Protects Access to Common Abortion Pill

Living Implants: Engineered Bacteria Trapped in Gel Fight Infections

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

A $122M boost for a fast, inside-the-body approach to cell therapy

Supreme Court Protects Access to Common Abortion Pill

Living Implants: Engineered Bacteria Trapped in Gel Fight Infections

A little science goes a long way.